These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 37626487)

  • 21. Medical conditions of primary care patients with documented cannabis use and cannabis use disorder in electronic health records: a case control study from an academic health system in a medical marijuana state.
    Padwa H; Huang D; Mooney L; Grella CE; Urada D; Bell DS; Bass B; Boustead AE
    Subst Abuse Treat Prev Policy; 2022 May; 17(1):36. PubMed ID: 35527269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cannabis use disorder among veterans: Comorbidity and mental health treatment utilization.
    Ecker AH; Lang B; Hogan J; Cucciare MA; Lindsay J
    J Subst Abuse Treat; 2020 Feb; 109():46-49. PubMed ID: 31856950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Different profile of substance abuse in relation to predominant polarity in bipolar disorder: The Vitoria long-term follow-up study.
    González-Pinto A; Alberich S; Barbeito S; Alonso M; Vieta E; Martínez-Arán A; Saenz M; López P
    J Affect Disord; 2010 Aug; 124(3):250-5. PubMed ID: 19959240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Systematic Review of the Clinical Effects of Cannabis and Cannabinoids in Posttraumatic Stress Disorder Symptoms and Symptom Clusters.
    Rodas JD; George TP; Hassan AN
    J Clin Psychiatry; 2024 Feb; 85(1):. PubMed ID: 38353645
    [No Abstract]   [Full Text] [Related]  

  • 25. Impact of substance use disorders on recovery from episodes of depression in bipolar disorder patients: prospective data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).
    Ostacher MJ; Perlis RH; Nierenberg AA; Calabrese J; Stange JP; Salloum I; Weiss RD; Sachs GS;
    Am J Psychiatry; 2010 Mar; 167(3):289-97. PubMed ID: 20008948
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Psychosocial and pharmacological treatments for cannabis use disorder and mental health comorbidities: a narrative review.
    Lees R; Hines LA; D'Souza DC; Stothart G; Di Forti M; Hoch E; Freeman TP
    Psychol Med; 2021 Feb; 51(3):353-364. PubMed ID: 33536109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Construct validity of DSM-5 cannabis use disorder diagnosis and severity levels in adults with problematic substance use.
    Fink DS; Shmulewitz D; Mannes ZL; Stohl M; Livne O; Wall M; Hasin DS
    J Psychiatr Res; 2022 Nov; 155():387-394. PubMed ID: 36182768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trends in documented cannabis use disorder among hospitalized adult epilepsy patients in the United States.
    Lekoubou A; Fox J; Bishu KG; Ovbiagele B
    Epilepsy Res; 2020 Jul; 163():106341. PubMed ID: 32361206
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Letter to the Editor: CONVERGENCES AND DIVERGENCES IN THE ICD-11 VS. DSM-5 CLASSIFICATION OF MOOD DISORDERS.
    Cerbo AD
    Turk Psikiyatri Derg; 2021; 32(4):293-295. PubMed ID: 34964106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cannabis use and medication nonadherence in bipolar disorder: A nationwide inpatient sample database analysis.
    Oladunjoye AF; Kaleem SZ; Suresh A; Sahni V; Thoonkuzhy MJ; Anugwom G; Oladunjoye O; Otuada D; Ikekwere J; Espiridion ED
    J Affect Disord; 2022 Feb; 299():174-179. PubMed ID: 34863715
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cannabis use disorder and post-traumatic stress disorder: The prevalence of comorbidity in veterans of recent conflicts.
    Bryan JL; Hogan J; Lindsay JA; Ecker AH
    J Subst Abuse Treat; 2021 Mar; 122():108254. PubMed ID: 33509412
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adolescent alcohol use predicts cannabis use over a three year follow-up period.
    Linakis JG; Thomas SA; Bromberg JR; Casper TC; Chun TH; Mello MJ; Richards R; Ahmad F; Bajaj L; Brown KM; Chernick LS; Cohen DM; Dean JM; Fein J; Horeczko T; Levas MN; McAninch B; Monuteaux MC; Mull CC; Grupp-Phelan J; Powell EC; Rogers A; Shenoi RP; Suffoletto B; Vance C; Spirito A;
    Subst Abus; 2022; 43(1):514-519. PubMed ID: 34236277
    [No Abstract]   [Full Text] [Related]  

  • 33. Cannabis use disorder and substance use treatment among U.S. adults.
    Choi NG; Moore J; Choi BY
    J Subst Use Addict Treat; 2024 Dec; 167():209486. PubMed ID: 39151799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of comorbid psychopathology with the duration of cannabis use disorders.
    Farmer RF; Kosty DB; Seeley JR; Gau JM; Duncan SC; Walker DD; Lewinsohn PM
    Psychol Addict Behav; 2016 Feb; 30(1):82-92. PubMed ID: 26766543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integrated cognitive behavioral therapy for comorbid cannabis use and anxiety disorders: A pilot randomized controlled trial.
    Buckner JD; Zvolensky MJ; Ecker AH; Schmidt NB; Lewis EM; Paulus DJ; Lopez-Gamundi P; Crapanzano KA; Bakhshaie J
    Behav Res Ther; 2019 Apr; 115():38-45. PubMed ID: 30442329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Demographic and clinical characteristics of treatment seeking women with full and subthreshold PTSD and concurrent cannabis and cocaine use disorders.
    Ruglass LM; Shevorykin A; Brezing C; Hu MC; Hien DA
    J Subst Abuse Treat; 2017 Sep; 80():45-51. PubMed ID: 28755772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cannabis use and cannabis use disorders among individuals with mental illness.
    Lev-Ran S; Le Foll B; McKenzie K; George TP; Rehm J
    Compr Psychiatry; 2013 Aug; 54(6):589-98. PubMed ID: 23375264
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cannabis use, cannabis use disorder and mental health disorders among pregnant and postpartum women in the US: A nationally representative study.
    Brown QL; Shmulewitz D; Sarvet AL; Young-Wolff KC; Howard T; Hasin DS
    Drug Alcohol Depend; 2023 Jul; 248():109940. PubMed ID: 37267745
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A 6-month, double-blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid-cycling bipolar disorder and Co-occurring substance abuse or dependence.
    Kemp DE; Gao K; Ganocy SJ; Elhaj O; Bilali SR; Conroy C; Findling RL; Calabrese JR
    J Clin Psychiatry; 2009 Jan; 70(1):113-21. PubMed ID: 19192457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical outcomes associated with comorbid posttraumatic stress disorder among patients with bipolar disorder.
    Passos IC; Jansen K; Cardoso Tde A; Colpo GD; Zeni CP; Quevedo J; Kauer-Sant'Anna M; Zunta-Soares G; Soares JC; Kapczinski F
    J Clin Psychiatry; 2016 May; 77(5):e555-60. PubMed ID: 27135375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.